We are live on ! Find out more
TVTX icon

Travere Therapeutics
TVTX

50 hedge funds and large institutions have $286M invested in Travere Therapeutics in 2014 Q1 according to their latest regulatory filings, with 50 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
+50
Holders Change %
–
% of All Funds
1.44%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.09%
New
50
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
QF
QVT Financial
New York
+$35.2M
2
Jennison Associates
Jennison Associates
New York
+$30.3M
3
BC
Broadfin Capital
New York
+$24.7M
4
PI
Putnam Investments
Massachusetts
+$21.7M
5
OM
Opaleye Management
Massachusetts
+$17.7M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
U
26
UBS
Switzerland
$805K +$584K +37,966 New
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$736K +$532K +34,600 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$652K +$471K +30,664 New
TA
29
Teachers Advisors
New York
$584K +$422K +27,450 New
Citadel Advisors
30
Citadel Advisors
Florida
$568K +$411K +26,718 New
Millennium Management
31
Millennium Management
New York
$545K +$395K +25,700 New
MLICM
32
Metropolitan Life Insurance Company (MetLife)
New York
$430K +$311K +20,202 New
RFC
33
Russell Frank Company
Washington
$341K +$372K +24,200 New
BG
34
BlackRock Group
United Kingdom
$329K +$238K +15,502 New
D.E. Shaw & Co
35
D.E. Shaw & Co
New York
$216K +$156K +10,135 New
BA
36
BlackRock Advisors
Delaware
$208K +$151K +9,812 New
TAM
37
Tocqueville Asset Management
New York
$159K +$115K +7,500 New
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
$126K +$91.2K +5,933 New
NFA
39
Nationwide Fund Advisors
Ohio
$124K +$89.7K +5,831 New
TRCT
40
Tower Research Capital (TRC)
New York
$110K +$79.7K +5,186 New
SCA
41
SAC Capital Advisors
Connecticut
$84K +$60.5K +3,932 New
Citigroup
42
Citigroup
New York
$43K +$30.7K +1,999 New
AllianceBernstein
43
AllianceBernstein
Tennessee
$38K +$27.8K +1,810 New
TC
44
TradeLink Capital
Illinois
$19K +$13.8K +900 New
SFPIA
45
Stevens First Principles Investment Advisors
California
$11K +$7.69K +500 New
Barclays
46
Barclays
United Kingdom
$11K +$7.98K +519 New
BlackRock
47
BlackRock
New York
$11K +$8.06K +524 New
CTC
48
Central Trust Company
Missouri
$6K +$4.61K +300 New
Morgan Stanley
49
Morgan Stanley
New York
$2K +$1.38K +90 New
TT
50
Tiedemann Trust
Delaware
$415 +$301K +19,593 New
1
2

TVTX Hedge Fund Activity: Q1 2014 in Review

50 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Travere Therapeutics (TVTX) for Q1 2014, worth a combined $286M.

Buyers outnumbered sellers: 50 funds opened new TVTX positions and 0 closed out — a net gain of 50 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was QVT Financial, opening a new position worth an estimated $35.2M.

  • 50 institutional investors held Travere Therapeutics (TVTX) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $286M of Travere Therapeutics stock for Q1 2014.
  • 50 funds opened new Travere Therapeutics positions in Q1 2014 and 0 closed out, a net change of +50 holders.
  • The largest Travere Therapeutics buyer in Q1 2014 was QVT Financial, an estimated $35.2M added.

Based on aggregated 13F filings for Q1 2014.